Bionano Genomics (BNGO) Interest Expenses (2017 - 2026)
Bionano Genomics (BNGO) posted Interest Expenses of $6.2 million for Q1 2026, up 465.76% sequentially from $1.1 million in Q4 2025, and up 661.27% YoY from $816000.0 in Q1 2025.
Bionano Genomics (BNGO) Interest Expenses (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Interest Expenses for 10 years, with the latest figure at $6.2 million in Q1 2026.
- Quarterly Interest Expenses rose 661.27% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (down 26.84% YoY) and the FY2025 annual result came in at $2.4 million, down 77.38% from the prior year.
- Interest Expenses advanced to $6.2 million in Q1 2026 per BNGO's latest filing, from $1.1 million in the prior quarter.
- Over five years, Interest Expenses peaked at $8.4 million in Q1 2023 and troughed at $75000.0 in Q4 2022.
- A 5-year average of $4.6 million and a median of $6.2 million in 2026 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses jumped 4698.86% in 2023, then slumped 85.48% in 2025.
- Over 5 years, Interest Expenses stood at $75000.0 in 2022, then soared by 1802.67% to $1.4 million in 2023, then plunged by 55.99% to $628000.0 in 2024, then soared by 74.84% to $1.1 million in 2025, then soared by 465.76% to $6.2 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $6.2 million, $1.1 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.12 Mn |
| Jun 30, 2026 | 6.12 Mn |
| Mar 31, 2026 | 6.21 Mn |
| Mar 31, 2026 | 6.21 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 4.78 Mn |
| Sep 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 816,000.00 |
| Mar 31, 2025 | 816,000.00 |
| Dec 31, 2024 | 628,000.00 |
| Dec 31, 2024 | 628,000.00 |
| Sep 30, 2024 | 6.72 Mn |
| Sep 30, 2024 | 6.72 Mn |
| Jun 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 6.80 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Mar 31, 2024 | 5.62 Mn |